The Beauty Health Company (SKIN) Tops Q4 EPS by 2c; Guides FY23 Revenue Above Street
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Equities climb as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
Tweet
Share
E-mailGet Alerts SKIN Hot Sheet
Join SI Premium – FREE
The Beauty Health Company (NASDAQ: SKIN) reported Q4 EPS of $0.06, $0.02 better than the analyst estimate of $0.04. Revenue for the quarter came in at $98.1 million versus the consensus estimate of $94.73 million.
GUIDANCE:
The Beauty Health Company sees FY2023 EPS of $450.00-$470.00, versus the consensus of $439.60.
For earnings history and earnings-related data on The Beauty Health Company (SKIN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Can JetBlue still avoid bankruptcy? Analysis says yes, but it won’t be easy
- Ponce Financial Group, Inc. (PDLB) Tops Q3 EPS by 24c
- Wells Fargo Highlights Top Shopping Center REITs Ahead of Q3 Earnings
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
